{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:53Z","timestamp":1792686233705,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacadv.2026.102933","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:39:57Z","timestamp":1781699997000},"page":"102933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Left Atrial Appendage Closure vs Direct Oral Anticoagulants in Atrial Fibrillation"],"prefix":"10.1016","volume":"5","author":[{"given":"Yi-Hsin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Han","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Nan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102933_bib1","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jacadv.2026.102933_bib2","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3390\/jcm14092914","article-title":"Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide","volume":"14","author":"Miceli","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib3","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.3390\/jcm12216909","article-title":"The left atrial appendage and atrial Fibrillation-A contemporary review","volume":"12","author":"Sulague","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/a-2469-4896","article-title":"An international consensus practical guide on left atrial appendage closure for the non-Implanting physician: executive summary","volume":"125","author":"Potpara","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacadv.2026.102933_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.102933_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib7","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus Nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left atrial appendage closure or anticoagulation for atrial fibrillation","volume":"394","author":"Doshi","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib12","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2026.102933_bib13","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2026.102933_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacadv.2026.102933_bib15","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/jce.16029","article-title":"Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: a subanalysis of the randomized PRAGUE-17 trial","volume":"34","author":"Branny","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib16","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1016\/j.hrthm.2025.07.051","article-title":"Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: long-term outcomes from 4 randomized trials","volume":"22","author":"Kaisaier","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacadv.2026.102933_bib17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.102933_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102933_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation","volume":"71","author":"Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib20","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacadv.2026.102933_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacep.2024.10.024","article-title":"State of the art in left atrial appendage occlusion","volume":"11","author":"Garg","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2026.0336","article-title":"Incidence, predictors, management, and clinical impact of major bleeding following left atrial appendage occlusion: the amulet IDE randomized clinical trial","volume":"11","author":"Schmidt","year":"2026","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.102933_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102933_bib24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacadv.2026.102933_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-asian cohorts","volume":"125","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacadv.2026.102933_bib26","article-title":"The 'Atrial Fibrillation Better Care' pathway for integrated care of atrial fibrillation: a systematic review and meta-analysis","author":"Romiti","year":"2026","journal-title":"Thromb Haemost"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26003546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26003546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:22:07Z","timestamp":1785529327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26003546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2772963X26003546"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102933","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left Atrial Appendage Closure vs Direct Oral Anticoagulants in Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102857","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102933"}}